Scientists test how common meds affect experimental drug
NCT ID NCT07242781
Summary
This early-stage study aims to understand how two common medications (itraconazole and rifampin) affect the body's processing of an experimental drug called AR-LDD. The research involves 42 healthy adult male volunteers who will take AR-LDD alone and then with each of the other medications. Researchers will measure drug levels in the blood and monitor for side effects to determine if these common drugs change how AR-LDD works in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Syneos Health Clinic
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.